C M Bidwell & Associates LTD Macrogenics Inc Transaction History

C M Bidwell & Associates LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$20.49 - $35.63 $167,915 - $291,987	-8,195 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$18.99 - $33.2 $28,484 - $49,800	1,500 Added 22.4%	8,195 $261,000
Q4 2020 Feb 16, 2021	BUY	$19.41 - $26.0 $129,949 - $174,070	6,695 New	6,695 $153,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.